PSYCHEMEDICS CORPORATION CMN - COM (PMD)

CUSIP: 744375205

Q4 2021 13F Holders as of 31 Dec 2021

Type / Class
Equity / COM
Total 13F shares
1,627,556
Share change
-70,816
Total reported value
$11,405,000
Price per share
$7.00
Number of holders
22
Value change
-$641,406
Number of buys
6
Number of sells
13

Quarterly Holders Quick Answers

What is CUSIP 744375205?
CUSIP 744375205 identifies PMD - PSYCHEMEDICS CORPORATION CMN - COM in SEC institutional holdings data.

Need full ownership history?
Open the full security ownership history page.

Institutional Holders of PSYCHEMEDICS CORPORATION CMN - COM (PMD) as of Q4 2021

As of 31 Dec 2021, PSYCHEMEDICS CORPORATION CMN - COM (PMD) was held by 22 institutional shareholders that filed Form 13F with the SEC. Together, they reported ownership of 1,627,556 shares. The largest 10 holders included RENAISSANCE TECHNOLOGIES LLC, CRAWFORD INVESTMENT COUNSEL INC, VANGUARD GROUP INC, RBF Capital, LLC, Invenomic Capital Management LP, BlackRock Inc., Ancora Advisors, LLC, CANNELL CAPITAL LLC, DIMENSIONAL FUND ADVISORS LP, and WEALTH EFFECTS LLC. This page lists 22 institutional shareholders reporting positions in this security for the Q4 2021 filing period.
Investor Option Weight % Change % Value $ * Price Shares Share Change Activity Report Period
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.